Medicine 2.0™ Conference - Call for Abstracts and Presentation Proposals

Toronto, Canada
September 4-5, 2008
Medicine 2.0™ is an international conference on Web 2.0 applications in health and medicine, organized and co-sponsored by the Journal of Medical Internet Research, the International Medical Informatics Association, the Centre for Global eHealth Innovation, CHIRAD, and a number of other sponsoring organizations.

Medicine 2.0™ will contain a mix of traditional academic/research, practice and business presentations, keynote presentations, and panel discussions to discuss emerging issues.

Medicine 2.0™ strives for an interdisciplinary mix of presenters from different disciplines (e.g. health care, social sciences, computer sciences, engineering, business) and with a different angle (research, practice, and business).

Participants are invited to either submit a 500 word abstract to propose a 15 minute single-presenter talk, or can submit a a 500 word panel proposal to present or discuss a topic in a 45-60 min session with 3-4 colleagues from other organizations/institutions (panel proposals with all authors from the same institution are discouraged). Panel presentations are the preferred format for non-research presentations.

Proposed Topics
(you will be asked to submit your panel proposal or scientific single-presenter abstract under one of the following broad topic headings)

  • Blogs
  • Building virtual communities and social networking applications for health professionals
  • Building virtual communities and social networking applications for patients and consumers
  • Business models in a Web 2.0 environment
  • Collaborative biomedical research, academic / scholarly communication, publishing and peer review
  • Consumer empowerment, patient-physician relationship, and sociotechnical issues
  • Ethical & legal issues, confidentiality and privacy
  • Health information on the web: Supply and Demand
  • Innovative RSS/XML applications
  • Personal health records and Patient portals
  • Public (e-)health, population health technologies, surveillance
  • Search, Collaborative Filtering and Recommender Technologies
  • Semantic Web ("Web 3.0") applications
  • The nature and dynamics of social networks in health
  • Usability and human factors on the web
  • Virtual (3D) environments, Second Life
  • Web 2.0 approaches for behaviour change, public health and biosurveillance
  • Web 2.0 approaches for clinical practice, clinical research, quality monitoring
  • Web2.0-based medical education and learning
  • Wikis
  • Youth and Digital Learning
  • other

Deadline for Abstracts: May 2nd, 2008.

Deadline for Early Bird and Speaker Registration: June 30th, 2008.

For further information, please visit:
http://www.medicine20congress.com

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech advance COVID-19 vaccine strat…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind, Phase 2 study to...

New needle-free nasal vaccine shows promise for CO…

New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mB...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Disparities in United States COVID-19 vaccine dist…

When reports showed COVID-19 vaccination rates were lower among racial/ethnic minority groups, most discussions focused on mistrust and misinformation among these populat...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

GSK signs agreement to support pandemic preparedne…

GSK plc (LSE/NYSE: GSK) announced it had signed a framework contract with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA) for t...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

Scientists develop new biomimetic formulation for …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore ...